PTP1B inhibition suggests a therapeutic strategy for Rett syndrome

The X-linked neurological disorder Rett syndrome (RTT) presents with autistic features and is caused primarily by mutations in a transcriptional regulator, methyl CpG–binding protein 2 (MECP2). Current treatment options for RTT are limited to alleviating some neurological symptoms; hence, more effec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Invest
Autors principals: Krishnan, Navasona, Krishnan, Keerthi, Connors, Christopher R., Choy, Meng S., Page, Rebecca, Peti, Wolfgang, Van Aelst, Linda, Shea, Stephen D., Tonks, Nicholas K.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4563751/
https://ncbi.nlm.nih.gov/pubmed/26214522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI80323
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars